focus -WSS

focus

author：explore 2025-09-28 21:56:34 - browse：321

ESMO signage in Madrid. — At ESMO 2023, antibody-drug conjugates were featured prominently. Andrew Joseph/STAT

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting, a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one). Multiple ADC studies were presented at the meeting’s top sessions. ADCs were, in short, the belle of the cancer research ball.

The thing is, ADCs are actually quite an old approach.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： There's no autism epidemic. It's an autism diagnosis epidemic

WSS

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Study says nonprofit hospitals fall short in charity care spending

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Rock icon Freddie Mercury pre

knowledge

focus

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

DIEP, the 'gold standard' of breast reconstruction, is under threat

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Drug repurposing or repositioning? The language matters

New company forms to vet health AI models, root out weaknesses

Medicare details structure of new drug price negotiation program

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Psychedelics group wrestles with new pharma identity

Patient advocates debate FDA's accelerated approval process

knowledge

Special counsel alerts court to Trump’s social media post

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

New company forms to vet health AI models, root out weaknesses

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Parkland mass shooting to be reenacted for lawsuit

Will generative AI in health care meet the fate of IBM's Dr. Watson?

focus

hotspot

focus

knowledge